RenovoRx Capex Per Share from 2010 to 2024

Stocks . USA . 
Stock . RenovoRx
RNXT Stock  USD 1.26  0.10  7.35%   
RenovoRx Capex Per Share yearly trend continues to be comparatively stable with very little volatility. Capex Per Share will likely drop to 0 in 2024. From the period from 2010 to 2024, RenovoRx Capex Per Share quarterly data regression had r-value of (0.57) and coefficient of variation of  5.72. View All Fundamentals
 
Capex Per Share  
First Reported
2010-12-31
Previous Quarter
0.001511
Current Value
0.001343
Quarterly Volatility
0.00009418
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check RenovoRx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RenovoRx's main balance sheet or income statement drivers, such as Net Interest Income of 116.5 K, Interest Income of 64.3 K or Depreciation And Amortization of 5.1 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. RenovoRx financial statements analysis is a perfect complement when working with RenovoRx Valuation or Volatility modules.
  
Check out the analysis of RenovoRx Correlation against competitors.
For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for RenovoRx Stock Analysis

When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY